In vitro IgG1 alloreactive antibody production by circulating memory cells in humans

Clinical Nephrology

Volumn 50, Issue 1, 1998, Pages 21-27

  Okasha, K ^a   Yang, H ^a   Shoker, A S ^a  

^a ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Allopeptides; Alloreactive memory cells; Cytokines; IgG1; IgG1 antibody; Interleukin; Uremic patients

Indexed keywords

ALLOANTIGEN; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE; OKT 3; POKEWEED MITOGEN;

ADULT; ALLOIMMUNITY; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CELL ACTIVATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEMORY CELL; PERIPHERAL LYMPHOCYTE; T LYMPHOCYTE; UREMIA; VIRUS TRANSFORMATION;

ADULT; ANALYSIS OF VARIANCE; ANTIBODY-PRODUCING CELLS; CELLS, CULTURED; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; ISOANTIBODIES; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; T-LYMPHOCYTES, HELPER-INDUCER; UREMIA;

EID: 0031825115     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Bevan MJ 1984 High determinant density may explain the phenomenon of alloreactivity. Immunol Today 5: 128
2. Borrebaeck CAK 1989 Strategy for the production of human monclonal antibodies using in vitro activated B cells. J Immunol Methods 123: 157-165
3. Braun WE 1989 Laboratory and clinical management of the highly sensitized organ transplant recipient. Human Immunol 26: 245-260
4. Braun WE 1997 The alloimmunized patient: Monitoring and therapeutics. Am J Med Sci 313: 279-282
5. Casali P, Notkins AL 1989 Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes. Ann Rev Immunol 7: 513-535
6. Crain MJ, Sanders SK, Butler JL, Cooper MD 1989 Epstein-Barr virus preferentially induces proliferation of primed B cells. J Immunol 143: 1543-1548
7. Dembech C, Quinti I, Cimignoli E, Albi N, Terenzi A, Gerli R, Galandrini R, Grignani F, Velardi A 1992 Human T-helper clones induce IgG production in a subclass-specific fashion. Cellular Immunology 139: 306-317
8. Finkelman FD, Holmes J, Katona IM 1990 Lymphokine control of in vivo immunoglobulin isotype selection. Annu Rev Immunol 88: 303-333
9. Fans G, Uytdehagg CM, Loggen HG, et al. 1985 Human peripheral blood lymphocytes from recently vaccinated individuals produce both type specific and intertypic cross reacting neutralizing antibody on in vitro stimulation with one type of poliovirus. J Immunol 135: 3094-3101
10. France-Transplant, in Rapport Annuel 1990. Bulletin No. 8, April 1991
11. Freitas AA, Rocha BB 1993 Lymphocyte lifespans: Homeostasis, selection and competition. Immunol Today 14: 25-29
12. Gjertson D 1991 Survival trends in long-term first cadaver-donor kidney transplants. In: Terasaki PI, Cecka JM (eds.) Clinical Transplants. UCLA Tissue Typing Laboratory, Los Angeles, CA: pp 225-235
13. Ikematsu H, Goldfarb IS, Harindranath N, Kasaian MT, Casali P 1992 Generation of human monoclonal antibody-producing cell lines by Epstein-Barr Virus (EBV)-transformation of B lymphocytes and somatic cell hybridization techniques. J Tiss Cult Meth 14: 9
14. Jindal KK, Goldstein MB 1988 Urea kinetic modelling in chronic hemodialysis: Benefits, problems and practical solutions. Seminars in Dialyis 1: 82-85
15. Kehrl JH, Fauci AS 1983 Activation of human B lymphocytes after immunization with pneumococcal polysaccharides. J Clin Invest 71: 1032-1040
16. Keown PA 1987 The highly sensitized patient: Aetiology, impact and management. Transplant Proc 19: 74-78
17. Kerman RH, Orosz CG, Lorber MI 1997 Clinical relvance of anti-HLA antibodies pre and post transplant. The American Journal of the Medical Sciences 313: 275-278
18. Kerman RH, Susskind B, Buelow R, et al. 1996 Correlation of Elisa-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 62: 201-205
19. Kozbor D, Roder JC 1984 In vitro stimulated lymphocytes as a source of human hybridomas. Eur J Immunol 12: 23-27
20. Lane HC, Volkman DJ, Whalen G, Fauci AS 1981 In vitro antigen-induced, antigen-specific antibody production in man. Specific and polyclonal components, kinetics and cellular requirements. J Exp Med 154; 1043-1057
21. Liu Z, Sun Y, Xi Y, Maffei A, Reed E, Harris P, Suciu-Foca N 1993 Contribution of direct and indirect recognition pathways to T cell alloreactivity. J Exp Med 177: 1643-1650
22. Matzinger P, Bevan MJ 1977 Hypothesis: Why do so many lymphocytes respond to major histocompatibility antigens? Cell Immunol 29: 1-5
23. Mohanakumar T, Waldrep JC, Phibs M, Mendez-Piccon G, Kaplan AM, Lee HM 1981 Serological characterization of antibodies eluted from chronologically rejected human renal allografts. Transplantation 32: 61-66
24. Nakagawa T, Hirano T, Nakagawa N, Yoshizaki K, Kishimoto T 1985 Effect of recombinant IL 2 and γ-IFN on proliferation and differentiation of human B cells. J Immunol 134: 359-966
25. Okasha K, Saxena A, El-Bedowey M, Shaker A 1997 Immunoglobulin G Subclasses and susceptibility to allosensitization in humans. Clin Nephrol 48: 165-172
26. Palmer A, Bewick M, Kennedy L, Welsh K, Taube D 1989 Anti-HLA antibodies following the transplantation of highly sensitized renal allograft recipients. Transplant Proc 21: 766-767
27. Quinn SM, Zhang JB, Gunsolley JC, Schenkein JG, Schenkein HA, Tew JG 1996 Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients. Infect-Immun 64: 2500-2505
28. Rosen A, Gergely P, Jondal M, Klein G, Britton S 1977 Polyclonal Ig production after Epstein-Barr virus infection of human lymphocytes in vitro. Nature 267: 52-54
29. Shoker A, Miller R, Uldall R, Friedman E, Angra S, Cardella CJ 1995 Lack of enhanced T-helper cell function in uremic patients with circulating alloreactive antibodies. J Am Soc Neph 5: 1441-1450
30. Sprent J, Miller JFAP 1976 Fate of H2-activated T lymphocytes in syngenic hosts. III. Differentiation into long-lived recirculating memory cells. Cell Immunol 21: 314-326
31. Stevens R, Dichek D, Keld B, Heiner D 1983 IgG1 is the predominant subclass of in vivo-and in vitro-produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol 3: 65-69
32. Stevens RH, Macy E, Morrow C, Saxon A 1979 Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J Immunol 122: 2498
33. Stevems RH, Saxon A 1978 Immunoregulation in humans. Control of antitetanus toxoid antibody production after booster immunization. J Clin Invest 62: 1154-1160
34. Tabi Z, Lynch F, Ceredig R, Allan JE, Doherty PC 1988 Virus-specific memory T cells are Pgp-1+ and can be selectively activated with phorbol ester and calcium ionophore. Cell Immunol 113: 268-277
35. Taube D 1990 Immunoadsorption in the sensitized transplant recipient. Kidney Int Nephrology Forum 38: 350-358
36. Thiele CJ, Morrow CD, Stevens RH 1981 Multiple subsets of antitetanus toxoid antibody-producing cells in human peripheral blood differ by size, expression of membrane receptors, and mitogen reactivity. J Immunol 126: 1146-1153
37. Tsutsumi Y, Kakumu S, Wakita T, Yoshioka K, Ishikawa T 1990 In vitro production of antibody to hepatitis B core and E antigens by peripheral blood mononuclear cells in patients with chronic hepatitis B virus infection. J Immunol 144: 2389-2393
38. Vendrell JP, Segondy M, Fournier AM, Huguet F, Reynes J, Ducos J, Serre A 1991 Spontaneous in vitro secretion of antibody to cytomegalovirus (CMV) by human peripheral blood mononuclear cells: a new approach to studying the CMV-immune system interaction. JID 164: 1-7
39. Weimer R, Daniel V, Pomer S, Opelz G 1989 B lymphocyte response as an indicator of acute renal transplant rejection. I. Immunoglobulin-secreting cells in peripheral blood. Transplantation 48: 569-572
40. Zhuoru L, Braunstein N, Suciu-Foca N 1992 T cell recognition of allopeptides in context of syngenic MHC. J Immunol 148: 35-40